Literature DB >> 16738534

Reduced expression of Toll-like receptor 4 contributes to impaired cytokine response of monocytes in uremic patients.

M Ando1, A Shibuya, K Tsuchiya, T Akiba, K Nitta.   

Abstract

Toll-like receptors (TLRs) play a pivotal role in pathogen recognition and subsequent cytokine synthesis by immune cells. Uremic patients have a high infectious morbidity, but it remains unclear if this arises from the defective innate immune responses related to TLRs. We studied TLR4 expression in monocytes and their intracellular cytokine synthesis in response to lipopolysaccharide (LPS) stimulation in 35 predialysis patients with chronic kidney disease (CKD) with or without predisposition to bacterial infections and 16 age-matched controls. Expression of TLR4 in unstimulated peripheral monocytes was determined by staining with anti-TLR4 antibody and analysis with flow cytometry. Monocytes were then stimulated by LPS, labeled with anti-CD14 antibody, and subjected to intracellular cytokine staining and flow cytometry. Tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, IL-6, and IL-8 synthesis was examined in CD14(+) monocytes. TLR4 expression was constitutively diminished in CKD patients with reduced expression being more severe in those CKD patients who were predisposed to infections. Monocytes from these infection prone CKD patients exhibited significantly reduced synthesis of TNF-alpha, IL-1beta, IL-6, and IL-8 in response to LPS challenge compared with those from control subjects. The intensity of synthesis of each cytokine significantly correlated with TLR4 expression levels in monocytes (P<0.01). The capacity of monocytes to synthesize proinflammatory cytokines was significantly reduced in infection prone CKD patients, and this may possibly be due to the reduced monocyte expression of TLR4. Abnormal TLR4 expression by monocytes may play a role in the susceptibility of such patients to bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16738534     DOI: 10.1038/sj.ki.5001548

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  25 in total

1.  Proton Pump Inhibitor-Associated C. difficile Infection in a Peritoneal Dialysis Patient.

Authors:  Susan L Ziolkowski; Michelle H Malabanan; Scott E Liebman
Journal:  Perit Dial Int       Date:  2015 Sep-Oct       Impact factor: 1.756

2.  Decreased number of CD14+TLR4+ monocytes and their impaired cytokine responses to lipopolysaccharide in patients with chronic kidney disease.

Authors:  Zhi Liu; Yan-Hong Kan; Yu-Dan Wei; Xiu-Jiang Li; Fan Yang; Yue Hou; Yu-Jun Du
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

Review 3.  The immunoregulatory function of vitamin D: implications in chronic kidney disease.

Authors:  Kevin A Sterling; Parham Eftekhari; Matthias Girndt; Paul L Kimmel; Dominic S Raj
Journal:  Nat Rev Nephrol       Date:  2012-05-22       Impact factor: 28.314

4.  Primed monocytes: putative culprits of chronic low-grade inflammation and impaired innate immune responses in patients on hemodialysis.

Authors:  Hye Won Kim; Young Seok Woo; Ha Na Yang; Hye Min Choi; Sang Kyung Jo; Won Yong Cho; Hyoung-Kyu Kim
Journal:  Clin Exp Nephrol       Date:  2010-12-09       Impact factor: 2.801

Review 5.  Secondary Immunodeficiency Related to Kidney Disease (SIDKD)-Definition, Unmet Need, and Mechanisms.

Authors:  Stefanie Steiger; Jan Rossaint; Alexander Zarbock; Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2021-12-14       Impact factor: 10.121

6.  Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.

Authors:  Jin Ma; Huiling Wu; Cathy Y Zhao; Usha Panchapakesan; Carol Pollock; Steven J Chadban
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

7.  Reduced frequency of a CD14+ CD16+ monocyte subset with high Toll-like receptor 4 expression in cord blood compared to adult blood contributes to lipopolysaccharide hyporesponsiveness in newborns.

Authors:  Sigifredo Pedraza-Sánchez; Amy G Hise; Lakshmi Ramachandra; Fabian Arechavaleta-Velasco; Christopher L King
Journal:  Clin Vaccine Immunol       Date:  2013-04-17

Review 8.  Aspects of immune dysfunction in end-stage renal disease.

Authors:  Sawako Kato; Michal Chmielewski; Hirokazu Honda; Roberto Pecoits-Filho; Seiichi Matsuo; Yukio Yuzawa; Anders Tranaeus; Peter Stenvinkel; Bengt Lindholm
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-13       Impact factor: 8.237

Review 9.  Immune cell dysfunction and inflammation in end-stage renal disease.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2013-03-19       Impact factor: 28.314

10.  High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD).

Authors:  Annette Bruchfeld; Abdul Rashid Qureshi; Bengt Lindholm; Peter Barany; Lihong Yang; Peter Stenvinkel; Kevin J Tracey
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.